Virtus Convertible & Income Fund II (NYSE:NCZ – Get Free Report) was the target of a significant decline in short interest in November. As of November 30th, there was short interest totalling 243,900 shares, a decline of 21.7% from the November 15th total of 311,600 shares. Based on an average daily trading volume, of 414,600 shares, the days-to-cover ratio is currently 0.6 days.
Virtus Convertible & Income Fund II Stock Down 0.3 %
Shares of NCZ stock traded down $0.01 during trading hours on Friday, reaching $3.28. 238,664 shares of the stock were exchanged, compared to its average volume of 479,953. The business’s fifty day moving average is $3.18 and its two-hundred day moving average is $3.04. Virtus Convertible & Income Fund II has a 12-month low of $2.70 and a 12-month high of $3.36.
Virtus Convertible & Income Fund II Announces Dividend
The company also recently disclosed a monthly dividend, which will be paid on Friday, March 28th. Stockholders of record on Thursday, March 13th will be issued a $0.12 dividend. The ex-dividend date is Thursday, March 13th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 43.90%.
Institutional Investors Weigh In On Virtus Convertible & Income Fund II
About Virtus Convertible & Income Fund II
Virtus Convertible & Income Fund II is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Allianz Global Investors U.S. LLC. It invests in fixed income markets of the United States. The fund primarily invests in convertible securities and non-convertible high-yield bonds rated below investment grade.
Further Reading
- Five stocks we like better than Virtus Convertible & Income Fund II
- Trading Halts Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Buy P&G Now, Before It Sets A New All-Time High
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Effectively Use the MarketBeat Ratings Screener
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Virtus Convertible & Income Fund II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus Convertible & Income Fund II and related companies with MarketBeat.com's FREE daily email newsletter.